Dr. Gina Gorodezky

About the Doctor

Education • Medical Surgeon graduated from the Universidad Autonoma de Mexico • Postgraduate studies in Hemato-Oncology at the MD Anderson Cancer Institute, Houston, Texas • Attending Physician, Hemato-Oncology Service, Instituto Nacional de Cancerologia • Diploma in Thanatology from the Universidad Autonoma de Mexico Academic Activities • Invited Professor, National AIDS Congress • Invited Professor, International Oncology Nursing Congress • Head of Lymphomas and AIDS, Instituto Nacional de Cancerologia • International Oncology Congress • Thanatology Counselor, Hospital Gabriel Mancera Research Study, presentation, and publication of various studies on the following topics: • Chromosomes in Leukemia, International Oncology Congress • Hemophagocytic Syndrome, ASCO Congress • Multiple Myeloma and Refractory Myeloma • Refractory Lymphomas, International Hematology Congress • Effects of Electromagnetic Fields on the human body Awards • "Aida Weiss" Award for Scientific Research Education • 1979-1984 Universidad Nacional Autonoma de Mexico, Medical Surgeon degree • 1984-1985 Hospital General de Mexico, of the S.S.A., Undergraduate Rotating Internship • 1985-1986 Instituto Nacional de Cardiologia Dr. Ignacio Chavez, Research Social Service • 1986-1989 The University of Texas System Cancer Center, MD Anderson and Tumor Institute, Postgraduate studies in Hemato-Oncology • 1989-1991 Instituto Nacional de Cancerologia, attending physician in the Hemato-Oncology Service • 1995-1999 Diploma in Thanatology at the Universidad Nacional Autonoma de Mexico • 2008 Good Clinical Practices Course, Roche • 2011 Good Clinical Practices Course, Pfizer • 2012 National Research Ethics Committees Course, Comision Nacional de Bioetica (CONBIOETICA) Research Projects 1985 "Interaction between Anticoagulants and Indomethacin," work presented at the National Rheumatology Congress, February 1986. 1985 - 1986 "Application of Isoproterenol Intravenous Infusion as a Diagnostic Procedure for Myocardial Ischemia," work presented at the 10th International Cardiology Congress, September 1986, and at the 10th National Cardiology Congress, November 1987; published in the "Archivos" journal of the Instituto Nacional de Cardiologia. 1986 "Treatment of Patients with Chronic Lymphocytic Leukemia with High Doses of Leukeran and Prednisone," work presented at the Annual Hematology Session of MD Anderson Hospital, which became a research protocol that is still used today. 1987 "Anti-emetic Treatment for Chemotherapy Patients," work presented at the General Session of MD Anderson Hospital and still used today in treating these patients. 1988 - 1989 "A-DHAP in the Treatment of Patients with High-Grade Malignancy Lymphoma," work presented at various sessions of MD Anderson Hospital and became a research protocol that in turn led to other protocols, with other applications. 1989 "Treatment of Patients with Lymphoma and HIV+," this protocol was drawn up in September 1989 and has been used to treat several patients with lymphomas and HIV infection. It is currently still used at the Instituto Nacional de Cancerologia. 1989 "Randomized Prospective Study to compare the effectiveness and toxicity of first, second, and third generation regimens in the treatment of Aggressive Diffuse Non-Hodgkin Lymphomas," this protocol began in November 1989. 1989 "Electrophysiological Alterations in Transformed Blood Cell Populations in Their Acute and Chronic Phase," this project began in August 1989 and ended in August 1990; it was presented at the 33rd National Congress of Physiological Sciences. 1989 "Neoplasms Associated with Human Immunodeficiency Virus Type 1. A Multidisciplinary Effort," this project began in December 1989. On July 16, 1990, it was approved by the Epidemiology Advisory Council (CAE) for funding. In October 1990 it won the "Aida Weiss" award, supporting oncological research. 1990 "Value of Upper Digestive Tract Endoscopy in the Staging of Malignant Lymphomas," February 1990, currently still under study. 1990 "The HIV-1, Associated Malignancies in Mexico a Case-Control Study," March 1990, was approved by Conasida, Rockefeller Foundation, and Kellogg Foundation for funding. 1990 "Expression of the Multidrug Resistance Gene (MDR) in Leukemias." It began in August 1990 and is currently still under study with preliminary results. 1990 "High Doses of Melphalan and Prednisone in the Treatment of Refractory Myeloma," began in March 1990 and the study is currently ongoing. 1990 "Randomized Study of Patients with Multiple Myeloma Using VAD vs VMCP," this study began in April 1990 and is currently ongoing. 1990 "The Hematophagocytic Syndrome (HPS) as a Cause of Pancytopenia in Malignant Lymphoproliferative Disorders," this work was presented at the ASCO Congress in May 1990 and was published in the "Proceedings of ASCO" journal in May 1990. 1990 "Chromosome Studies in Leukemia," study that was accepted and presented at the International Oncology Congress in August 1990. Academic Activities 1989 "2nd National Congress on AIDS," INVITED PROFESSOR, Lymphomas and AIDS, November 1989 1989 Head of Lymphomas and AIDS at the Cancer and AIDS Clinic of the Instituto Nacional de Cancerologia 1990 "6th International Congress of Oncology Nursing," invited professor, Leukemias, February 1990 1990 "Blood Components," invited professor, Plasma and its Derivatives, April 1990 1990 American Society of Clinical Oncology Congress, work on Hemophagocytic Syndrome 1990 International Oncology Congress, presentation of the work "Chromosomal studies in leukemia patients" 1990 "33rd National Congress of Physiological Sciences," presentation of the work "Membrane Alterations," August 1990 1990 "International Course on Cancer and AIDS," invited professor, Lymphomas and AIDS, experience of the Lymphoma and AIDS Cooperative Group in Mexico 1990 "International Course on Cancer and AIDS," invited professor, Lymphomas and AIDS, experience of the Lymphoma and AIDS Cooperative Group in Mexico. 1990 "Aida Weiss" Award for scientific research for the project "Neoplasms Associated with Human Immunodeficiency Virus Type 1," a multidisciplinary effort 1990 "32nd International Congress of Hematology" and "32nd National Congress of Hematology," presentation of the work "DHAP in the Treatment of Refractory Lymphomas," November 1990 1991 - 1994 "Effects of Electromagnetic Fields on the Human Body," study conducted in Mexico City with the objective of discovering the incidence of malignant neoplasms in people who live and/or work near high-voltage cables or electrical substations. This study included the following activities: • Sampling and measurement of electromagnetic fields at all substations in the Valle de Mexico. Clinical and pathological study of workers at Compania de Luz y Fuerza (CLF) and Comision Federal de Electricidad (CFE), confirming malignant neoplasms produced by continuous exposure to electromagnetic waves. • Joint study with the Karolinska Institute of Sweden and the Institute of Physics of England on the effects of electromagnetic fields. • Presentation to various Federal Government bodies (Presidency and Attorney General's Office for the Environment) and to the State of Mexico, of the study results, achieving the shutdown of construction of an electrical substation in a residential area. • Writing of various articles for Mexico City newspapers (El Universal, Excelsior, la Jornada) on the risks of high-voltage cables in producing cancer. • Production of a complete segment for the "60 Minutes" program on the risk of living near high-voltage lines. • Participation in various radio programs (Fuego Cruzado, Monitor) in interviews on the risks of cancer in relation to electromagnetic waves. • Appearance on the television program "Un Nuevo Dia," on the risks of sun exposure and skin cancers. 2011 "Approaching Temporomandibular Disorders From a New Direction: A Randomized Controlled Clinical Trial of the TMDes(TM) Ear System," work published in "The Journal of Craniomandibular Practice," November 2011. Other Activities 1995 - 1999 Participation in the 3rd National Thanatology Congress 1999 - 2005 Thanatology Counseling at Hospital Gabriel Mancera Professional Activity 1990 to date Medical office for patients with hematological and oncological disorders. Sur 132, Office 108 Mexico, D.F. tel: (55) 5516-5370 1996 - 2000 Launch of the Proyecto Cordon Vital, a company specialized in the management and storage of umbilical cord blood from newborns and in conducting stem cell studies. Acueducto Rio Hondo no. 2, Lomas Virreyes, 11000 Mexico, D.F., Tel: (55) 5540 61 41. 2000 to date Member of the Council and Medical Advisor of Cordon Vital 2005 - 2008 Medical Director of the Instituto Mexicano de Investigacion Clinica (IMIC), Durango no. 216, Col. Roma, 0670 Mexico, D.F., Tel: (55) 5511 91 11. • Responsible for communication with the various pharmaceutical companies in Mexico, the United States, the European Union, and Asia. • Also responsible for preparing feasibility studies, completing 785 feasibility studies. 2008 to date Medical and Clinical Operations Director of the Instituto Mexicano de Investigacion Clinica (IMIC) • Responsible for communication with the various pharmaceutical companies in Mexico, the United States, the European Union, and Asia. • Preparation of feasibility studies • Development and follow-up of 165 clinical research studies conducted to date.

Education

Frequently Asked Questions

Practice locations

Languages